Key points from article :
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $3 million to continue the study of the anti-aging abilities of a diabetes drug.
The five-year grant will allow Benjamin Miller, to continue his investigation of the ability of metformin, a diabetes drug, to slow the biological process of aging.
“We know exercise slows the aging process, but this drug could be an alternative for otherwise healthy people who don’t get much movement,” Miller said.
The study will observe metformin’s impact on animal models with different fitness levels.
